These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27067438)

  • 1. Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential.
    Färkkilä A; Zauli G; Haltia UM; Pihlajoki M; Unkila-Kallio L; Secchiero P; Heikinheimo M
    Tumour Biol; 2016 Sep; 37(9):11909-11916. PubMed ID: 27067438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis.
    Kyrönlahti A; Kauppinen M; Lind E; Unkila-Kallio L; Butzow R; Klefström J; Wilson DB; Anttonen M; Heikinheimo M
    Endocr Relat Cancer; 2010 Sep; 17(3):709-17. PubMed ID: 20554787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
    Haltia UM; Hallamaa M; Tapper J; Hynninen J; Alfthan H; Kalra B; Ritvos O; Heikinheimo M; Unkila-Kallio L; Perheentupa A; Färkkilä A
    Gynecol Oncol; 2017 Jan; 144(1):83-89. PubMed ID: 27871721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B.
    Färkkilä A; Koskela S; Bryk S; Alfthan H; Bützow R; Leminen A; Puistola U; Tapanainen JS; Heikinheimo M; Anttonen M; Unkila-Kallio L
    Int J Cancer; 2015 Oct; 137(7):1661-71. PubMed ID: 25808251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.
    Crosley P; Farkkila A; Jenner AL; Burlot C; Cardinal O; Potts KG; Agopsowicz K; Pihlajoki M; Heikinheimo M; Craig M; Fu Y; Hitt MM
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
    Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
    Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
    Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
    Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor.
    Färkkilä A; McConechy MK; Yang W; Talhouk A; Ng Y; Lum A; Morin RD; Bushell K; Riska A; McAlpine JN; Gilks CB; Unkila-Kallio L; Anttonen M; Huntsman DG
    J Mol Diagn; 2017 Jan; 19(1):126-136. PubMed ID: 27810330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors.
    Haltia UM; Pihlajoki M; Andersson N; Mäkinen L; Tapper J; Cervera A; Horlings HM; Turpeinen U; Anttonen M; Bützow R; Unkila-Kallio L; Carpén O; Wilson DB; Heikinheimo M; Färkkilä A
    J Endocr Soc; 2020 Apr; 4(4):bvaa034. PubMed ID: 32309755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse correlation between circulating levels of TNF-related apoptosis-inducing ligand and 17β-estradiol.
    Zauli G; Tisato V; Melloni E; Volpato S; Cervellati C; Bonaccorsi G; Radillo O; Marci R; Secchiero P
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E659-64. PubMed ID: 24446659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
    Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
    BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic analysis of stage 1 versus advanced adult granulosa cell tumors.
    Alexiadis M; Chu S; Leung D; Gould JA; Jobling T; Fuller PJ
    Oncotarget; 2016 Mar; 7(12):14207-19. PubMed ID: 26893359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro.
    Färkkilä A; Pihlajoki M; Tauriala H; Bützow R; Leminen A; Unkila-Kallio L; Heikinheimo M; Anttonen M
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1973-81. PubMed ID: 21994955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
    Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
    J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
    Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
    Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome.
    Zhang J; Zhu G; Wang X; Xu B; Hu L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):311-4. PubMed ID: 17641850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
    Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
    Tanaka H; Ito T; Kyo T; Kimura A
    Eur J Haematol; 2007 May; 78(5):389-98. PubMed ID: 17432976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
    Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
    Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.
    Fashedemi Y; Coutts M; Wise O; Bonhomme B; Baker G; Kelly PJ; Soubeyran I; Catherwood MA; Croce S; McCluggage WG
    Am J Surg Pathol; 2019 Sep; 43(9):1229-1238. PubMed ID: 31162286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.